Form 4: Edwards Lifesciences Executive Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Donald E. Bobo Jr., a CVP at Edwards Lifesciences, exercised stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.
Summary
- On August 14, 2024, Donald E. Bobo Jr., CVP of Strategy/Corporate Development at Edwards Lifesciences Corp, exercised employee stock options to acquire 5,000 shares of common stock at a price of $45.2767 per share.
- Simultaneously, Bobo sold 5,000 shares of common stock at a weighted average price of $66.084, with individual trades ranging from $65.76 to $66.62.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on December 14, 2023.
- Following these transactions, Bobo directly owns 46,935.7184 shares of common stock and indirectly owns 38,616.6145 shares through a 401(k) and 135,152 shares by trust.
- Bobo also continues to hold options for 50,500 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies. The use of 10b5-1 plans allows insiders to sell shares over a period of time, mitigating concerns about trading on non-public information.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a form of long-term incentive.
- The exercise and sale of shares by executives are typical events, and the reporting is mandated by the SEC to ensure transparency.
- The use of 10b5-1 plans is a standard practice to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the effect is likely minimal given the relatively small number of shares involved.
- The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2018-06-17 | Employee Stock Option Date Exercisable |
| 2023-12-14 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-08-14 | Date of transaction: Exercise of options and sale of shares |
| 2025-05-16 | Employee Stock Option Expiration Date |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.